Hodgkin Lymphoma Incidence and Mortality by Year, White Individuals, New York State, 1976-2020

Source: New York State Cancer Registry

Year of Diagnosis/Death Incidence Mortality
Males and Females Males Females Males and Females Males Females
Cases Rate per 100,000 Population 95% CI Cases Rate per 100,000 Males 95% CI Cases Rate per 100,000 Females 95% CI Deaths Rate per 100,000 Population 95% CI Deaths Rate per 100,000 Males 95% CI Deaths Rate per 100,000 Females 95% CI
1976 567 3.5 3.2-3.8 307 4.1 3.6-4.6 260 3.0 2.7-3.5 217 1.4 1.2-1.6 126 1.8 1.5-2.2 91 1.1 0.9-1.3
1977 537 3.4 3.1-3.7 302 4.1 3.6-4.6 235 2.8 2.5-3.2 225 1.5 1.3-1.7 128 1.9 1.6-2.3 97 1.2 1.0-1.5
1978 571 3.6 3.3-3.9 299 4.1 3.6-4.6 272 3.2 2.8-3.6 197 1.3 1.1-1.5 109 1.6 1.3-1.9 88 1.1 0.8-1.3
1979 575 3.8 3.4-4.1 313 4.5 4.0-5.0 262 3.2 2.8-3.6 170 1.1 1.0-1.3 97 1.5 1.2-1.8 73 0.9 0.7-1.1
1980 597 3.9 3.5-4.2 327 4.6 4.1-5.2 270 3.2 2.8-3.6 203 1.4 1.2-1.6 112 1.7 1.4-2.1 91 1.1 0.8-1.3
1981 564 3.6 3.3-4.0 300 4.1 3.7-4.6 264 3.2 2.8-3.6 176 1.2 1.0-1.4 98 1.5 1.2-1.8 78 0.9 0.7-1.2
1982 579 3.7 3.4-4.1 300 4.3 3.8-4.8 279 3.3 2.9-3.7 182 1.2 1.0-1.4 97 1.4 1.1-1.7 85 1.0 0.8-1.3
1983 546 3.6 3.3-3.9 312 4.4 3.9-5.0 234 2.8 2.5-3.2 152 1.0 0.8-1.2 88 1.3 1.0-1.6 64 0.7 0.5-0.9
1984 568 3.7 3.4-4.0 302 4.3 3.8-4.9 266 3.2 2.8-3.6 157 1.1 0.9-1.2 93 1.4 1.1-1.7 64 0.7 0.6-1.0
1985 606 4.0 3.6-4.3 330 4.6 4.1-5.2 276 3.4 3.0-3.8 155 1.0 0.8-1.2 84 1.2 0.9-1.5 71 0.8 0.6-1.1
1986 563 3.6 3.3-4.0 307 4.2 3.7-4.7 256 3.1 2.7-3.5 174 1.1 1.0-1.3 99 1.5 1.2-1.8 75 0.9 0.7-1.1
1987 521 3.4 3.1-3.8 268 3.8 3.3-4.3 253 3.2 2.8-3.6 140 0.9 0.8-1.1 86 1.2 1.0-1.5 54 0.7 0.5-0.9
1988 562 3.7 3.4-4.1 313 4.4 3.9-5.0 249 3.1 2.7-3.5 119 0.8 0.7-1.0 76 1.1 0.9-1.4 43 0.5 0.4-0.7
1989 557 3.7 3.4-4.0 311 4.4 3.9-4.9 246 3.1 2.7-3.5 149 1.0 0.9-1.2 95 1.4 1.2-1.8 54 0.7 0.5-0.9
1990 527 3.6 3.3-3.9 286 4.1 3.6-4.6 241 3.1 2.7-3.5 137 0.9 0.8-1.1 84 1.3 1.0-1.6 53 0.6 0.5-0.8
1991 546 3.7 3.4-4.0 291 4.2 3.7-4.7 255 3.3 2.9-3.7 110 0.7 0.6-0.9 61 0.9 0.7-1.2 49 0.6 0.4-0.8
1992 561 3.8 3.5-4.1 305 4.4 3.9-4.9 256 3.3 2.9-3.7 128 0.8 0.7-1.0 64 0.9 0.7-1.2 64 0.8 0.6-1.0
1993 505 3.5 3.2-3.8 251 3.6 3.2-4.1 254 3.3 2.9-3.7 102 0.7 0.5-0.8 55 0.8 0.6-1.1 47 0.6 0.4-0.8
1994 571 3.9 3.6-4.2 300 4.3 3.8-4.8 271 3.5 3.1-3.9 113 0.7 0.6-0.9 55 0.8 0.6-1.1 58 0.7 0.5-0.9
1995 514 3.6 3.3-3.9 277 4.0 3.5-4.5 237 3.2 2.8-3.6 100 0.7 0.5-0.8 50 0.7 0.5-1.0 50 0.6 0.4-0.8
1996 494 3.4 3.1-3.7 251 3.6 3.2-4.1 243 3.3 2.9-3.7 89 0.6 0.5-0.7 45 0.7 0.5-0.9 44 0.6 0.4-0.7
1997 482 3.4 3.1-3.7 268 3.8 3.4-4.3 214 2.9 2.5-3.4 96 0.6 0.5-0.8 53 0.8 0.6-1.0 43 0.5 0.4-0.7
1998 540 3.7 3.4-4.1 275 4.0 3.5-4.5 265 3.6 3.1-4.0 93 0.6 0.5-0.8 48 0.7 0.5-0.9 45 0.6 0.4-0.8
1999 503 3.5 3.2-3.8 269 3.8 3.4-4.3 234 3.1 2.7-3.6 83 0.5 0.4-0.7 39 0.6 0.4-0.8 44 0.5 0.4-0.7
2000 538 3.7 3.4-4.0 291 4.2 3.7-4.7 247 3.3 2.9-3.8 86 0.6 0.4-0.7 44 0.7 0.5-0.9 42 0.5 0.3-0.7
2001 538 3.7 3.4-4.0 278 4.0 3.5-4.5 260 3.5 3.1-4.0 85 0.6 0.4-0.7 45 0.6 0.5-0.9 40 0.5 0.3-0.6
2002 587 4.0 3.7-4.4 328 4.7 4.2-5.2 259 3.5 3.1-3.9 93 0.6 0.5-0.7 48 0.7 0.5-0.9 45 0.5 0.4-0.7
2003 516 3.6 3.3-3.9 282 4.0 3.6-4.5 234 3.1 2.7-3.6 70 0.5 0.4-0.6 32 0.5 0.3-0.6 38 0.5 0.3-0.6
2004 545 3.8 3.5-4.1 281 4.0 3.6-4.5 264 3.6 3.2-4.0 75 0.5 0.4-0.6 44 0.6 0.4-0.8 31 0.4 0.2-0.5
2005 554 3.9 3.5-4.2 305 4.4 3.9-4.9 249 3.4 3.0-3.9 70 0.4 0.3-0.6 34 0.5 0.3-0.7 36 0.4 0.3-0.6
2006 526 3.6 3.3-4.0 293 4.2 3.7-4.7 233 3.1 2.7-3.6 71 0.5 0.4-0.6 41 0.6 0.4-0.8 30 0.4 0.2-0.5
2007 535 3.7 3.4-4.0 266 3.8 3.3-4.3 269 3.6 3.2-4.1 84 0.5 0.4-0.7 42 0.6 0.4-0.8 42 0.5 0.3-0.6
2008 520 3.6 3.3-3.9 274 3.9 3.4-4.3 246 3.3 2.9-3.8 84 0.5 0.4-0.6 50 0.7 0.5-0.9 34 0.4 0.2-0.5
2009 527 3.7 3.3-4.0 293 4.1 3.7-4.6 234 3.2 2.8-3.7 63 0.4 0.3-0.5 35 0.5 0.3-0.7 28 0.3 0.2-0.5
2010 512 3.5 3.2-3.8 285 4.0 3.5-4.5 227 3.0 2.6-3.4 66 0.4 0.3-0.5 38 0.5 0.4-0.7 28 0.3 0.2-0.5
2011 522 3.6 3.3-4.0 290 4.1 3.7-4.6 232 3.2 2.8-3.6 69 0.4 0.3-0.5 43 0.6 0.4-0.8 26 0.3 0.2-0.4
2012 520 3.6 3.3-4.0 301 4.2 3.8-4.8 219 3.1 2.7-3.5 67 0.4 0.3-0.5 31 0.4 0.3-0.6 36 0.4 0.3-0.5
2013 500 3.4 3.1-3.8 244 3.4 3.0-3.9 256 3.5 3.1-4.0 55 0.3 0.2-0.4 27 0.4 0.2-0.5 28 0.3 0.2-0.4
2014 548 3.7 3.4-4.1 292 4.1 3.6-4.6 256 3.4 3.0-3.8 59 0.3 0.3-0.5 25 0.3 0.2-0.5 34 0.4 0.2-0.5
2015 474 3.3 3.0-3.7 269 3.8 3.4-4.3 205 2.9 2.5-3.3 53 0.3 0.2-0.4 26 0.4 0.2-0.5 27 0.3 0.2-0.4
2016 533 3.7 3.3-4.0 270 3.8 3.3-4.3 263 3.6 3.1-4.0 62 0.4 0.3-0.5 36 0.5 0.3-0.6 26 0.3 0.2-0.4
2017 485 3.3 3.0-3.6 268 3.7 3.2-4.2 217 3.0 2.6-3.4 47 0.3 0.2-0.4 25 0.3 0.2-0.5 22 0.2 0.1-0.3
2018 433 2.9 2.6-3.2 251 3.4 3.0-3.9 182 2.4 2.1-2.8 56 0.3 0.2-0.4 38 0.5 0.3-0.7 18 0.2 0.1-0.3
2019 489 3.4 3.1-3.7 260 3.6 3.2-4.1 229 3.2 2.8-3.7 52 0.3 0.2-0.4 35 0.4 0.3-0.6 17 0.2 0.1-0.3
2020 425 3.0 2.8-3.4 237 3.4 3.0-3.9 188 2.7 2.3-3.1 41 0.2 0.2-0.3 24 0.3 0.2-0.4 17 0.2 0.1-0.3

Notes

  • Incidence data are provisional, November 2022.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 20 cases or deaths per year are unstable and should be used with caution.
  • Cancer diagnoses trends in 2020 may have been affected by the coronavirus disease 19 (COVID-19) pandemic.
  • The data in this table are not identical to the data in the corresponding 2016-2020 incidence table. See the rationale in 'Considerations When Comparing Cancer Statistics Over Time'.
  • NYSCR mortality statistics might differ slightly from official mortality statistics due to the availability of additional demographic information.